Clinical Trial Update: Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM [Phase 3]

View source ↗

Summary

Phase 3 trial comparing elotuzumab with carfilzomib, lenalidomide, and dexamethasone (E-KRd) versus KRd in newly diagnosed multiple myeloma; currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (carfilzomib)
• DEXAMETHASONE (Dexamethasone)
• Elotuzumab (elotuzumab)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Wuerzburg University Hospital | Conditions: Newly Diagnosed Multiple Myeloma | Phase 3 | Status: ACTIVE_NOT_RECRUITING